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The relationship of plasma BNP, ANP, TNF-a and IL-6 levels to cardiac function
in patients with congestive heart failure
Li Xia, Kang Weiqiang
Shandong Uiniversity School of Medicine
Objectives: To study the relationship of the plasma brain natriuretic peptide
(BNP), atria natriuretic peptide (ANP), tumor necrosis factor-a (TNF-a) and
Interleukin-6 (IL-6) concentration with the severity of heart failure, the undering
heart disease and the left ventricular function in patients with congestive heart
failure (CHF).
Methods: Method 80 patients with CHF were recrited and divided into 3sub-
groups of NYHAII-IV, and 30 healthy persons were enlisted as control group. The
blood samples were obtained from all the subejects in fasting condion in the
morning. The levels of plasma BNP, ANP, TNF-a and IL-6 were determined by
radioimmunoassay. Left ventricular ejective fraction (LVEF) was mearured by
echocardiography.
Results: The plasma BNP, ANP, TNF-a and IL-6 concentrations were signiﬁcantly
higher in CHF groups than those in control group (P<0.01).They also increased
according to the severity of heart failure classiﬁed by NYHA0s classiﬁcation
(P<0.01).The plasma BNP level was signiﬁcantly higher in MI group than those in
VHD, HHD and DCM group (P<0.01). The levels of, ANP, TNF-a and IL-6 were
not related to the primary diease of CHF (P>0.05). The plasma levels BNP,
ANP, TNF-a and IL-6 had signiﬁcantly negtive correlation to LVEF (r¼-0.72,
-0.65, -0.54 and -0.58, P<0.01, 0.01, 0.05, 0.05).There were positive correlations
among the level of TNF-a and those of BNP, ANP, and IL-6 (r¼0.51, 0.45, 0.62,
P<0.01, 0.01, 0.001).
Conclusions: (1) BNP, ANP, TNF-a and IL-6 serving as neurocrines and cytokines
are involvedin the pathophysiology of CHF. They also increased according to the
severity of heart failure. (2) The plasma BNP concentrations is elevated more mark-
edly in CHF patients caused by myocardial infarction. (3) The plasma BNP con-
centration evaluates the left ventricular function better. (4) Neurocrines and cytokins
relate each other and both play important roles in the diagnosis and the risk of patients
with CHF.JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/CGW25-e5320
The correlation of plasma Gal-3 and NT-ProBNP level with the left ventricular
structure and function
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Objectives: Heart failure (HF) is a complex disorder in which a number of patho-
physiologic mechanisms participate, including inﬂammation, tissue remodeling,
neurohormonal and endocrine signaling, and interactions with the renal and nervous
systems. Recently, it has been suggested that NT-ProBNP and galectin-3 (Gal-3)
played a important role in the pathophysiology of HF and Gal-3 levels are associated
with an impaired outcome after short-term follow- up in HF patients. However, the
correlation between Gal-3 and NT-ProBNP in HF is unknown. Therefore, we
examined the level of plasma Gal-3 and NT-ProBNP to mark for tissue remodeling
and systolic function in patients with chronic HF and compared correlation between
them with heart failure degree.
Methods: We recruited 45 HF patients (thirty and three men and twelve women with
New York Heart Association (NYHA) Class II and III- IV who had been hospitalized
for HF and were followed for twelve months. The levels of plasma Gal-three and NT-
proBNP were developed by enzyme-linked immuno-sorbent assay.
Results: The level of Gal-3 and NT-ProBNP were signiﬁcantly higher in NYHA
functional class II and III compared with that in control (P<0.05 and P<0.01,
respectively). Multivariate linear regression analyses revealed that the levels of
plasma Gal-3 and NT-proBNP were positively correlated with LVEDD (r¼0.478,
P<0.01; r¼0.452, P<0.01), but negatively correlated with LVEF (r¼-0.409, P<0.01;
r¼-0.516, P<0.01). There were no signiﬁcant effects of medications on Gal-3 levels
during a week (P>0.05), whereas signiﬁcantly lower levels of NT-proBNP (P<0.05)
were seen compared with prior treatmen, meanwhile left ventricular end-diastolic
diameter (LVEDD) has no obvious change, but the ejection fraction decreased
obviously.
Conclusions: Our results suggested that Gal-3 is associated with the left ventricular
structure and function, and nearly have no effect with the treatment, indicating that
Gal-3 may have been involved in the process of left ventricular remodeling, and the
measurement of Gal-3 provided additional prognostic information compared with
NT-proBNP.ardiovascular Disease Clinical Research C189
